212 related articles for article (PubMed ID: 23026662)
1. Venous thromboembolic disease in patients with haemophilia.
Hermans C
Thromb Res; 2012 Oct; 130 Suppl 1():S50-2. PubMed ID: 23026662
[TBL] [Abstract][Full Text] [Related]
2. Surgery in patients with hemophilia: is thromboprophylaxis mandatory?
Ozelo MC
Thromb Res; 2012 Oct; 130 Suppl 1():S23-6. PubMed ID: 23026653
[TBL] [Abstract][Full Text] [Related]
3. Prevention of VTE Following total hip and knee arthroplasty in Hemophilia patients.
Stein MI; Park J; Raterman S
Orthopedics; 2011 May; 34(5):389-392. PubMed ID: 21553745
[TBL] [Abstract][Full Text] [Related]
4. [Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T; Malý R; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
[TBL] [Abstract][Full Text] [Related]
6. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
Ageno W; Spyropoulos AC; Turpie AG
Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolic disease after total hip and knee arthroplasty.
Haas SB; Barrack RL; Westrich G
Instr Course Lect; 2009; 58():781-93. PubMed ID: 19385586
[TBL] [Abstract][Full Text] [Related]
8. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis of venous thromboembolic disease in high-risk orthopedic surgery].
Meza Reyes GE; Esquivel Gómez R; Martínez del Campo Sánchez A; Espinosa-Larrañaga F; Martínez Guzmán MÁ; Torres González R; de la Fuente Zuno JC; Méndez Huerta JV; Villalobos Garduño E; Cymet Ramírez J; Ibarra Hirales E; Díaz Borjón E; Aguilera Zepeda JM; Valles Figueroa JF; Majluf-Cruz A;
Gac Med Mex; 2012; 148(2):144-52. PubMed ID: 22622314
[TBL] [Abstract][Full Text] [Related]
10. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolic events following foot and ankle surgery in the English National Health Service.
Jameson SS; Augustine A; James P; Serrano-Pedraza I; Oliver K; Townshend D; Reed MR
J Bone Joint Surg Br; 2011 Apr; 93(4):490-7. PubMed ID: 21464488
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
Kaatz S; Spyropoulos AC
Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
Kwong LM
Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
[TBL] [Abstract][Full Text] [Related]
15. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
Huang J; Cao Y; Liao C; Wu L; Gao F
Thromb Haemost; 2011 Feb; 105(2):245-53. PubMed ID: 20941455
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.
Kinov P; Tanchev PP; Ellis M; Volpin G
Int Orthop; 2014 Jan; 38(1):169-75. PubMed ID: 24114249
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
18. The role of apixaban for venous and arterial thromboembolic disease.
Prom R; Spinler SA
Ann Pharmacother; 2011 Oct; 45(10):1262-83. PubMed ID: 21954450
[TBL] [Abstract][Full Text] [Related]
19. [News on venous thromboembolic disease].
Arcelus JI; García-Bragado F; Jiménez D; Lozano Sánchez FS; Lecumberri R; Román Sánchez P;
Rev Clin Esp; 2012 Sep; 212(8):391-402. PubMed ID: 22621713
[TBL] [Abstract][Full Text] [Related]
20. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
